Home Applications 217439 Application 217439
Type NDA
Sponsor PFIZER Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TALZENNA TALAZOPARIB TOSYLATE CAPSULE;ORAL EQ 0.1MG BASE Yes No 002 TALZENNA TALAZOPARIB TOSYLATE CAPSULE;ORAL EQ 0.25MG BASE Yes No 003 TALZENNA TALAZOPARIB TOSYLATE CAPSULE;ORAL EQ 0.35MG BASE Yes No 004 TALZENNA TALAZOPARIB TOSYLATE CAPSULE;ORAL EQ 0.5MG BASE Yes No 005 TALZENNA TALAZOPARIB TOSYLATE CAPSULE;ORAL EQ 0.75MG BASE Yes No 006 TALZENNA TALAZOPARIB TOSYLATE CAPSULE;ORAL EQ 1MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217439-001 TALZENNA TALAZOPARIB TOSYLATE EQ 0.1MG BASE CAPSULE / ORAL RLD 2024-03-07 N217439-002 TALZENNA TALAZOPARIB TOSYLATE EQ 0.25MG BASE CAPSULE / ORAL RLD 2024-03-07 N217439-003 TALZENNA TALAZOPARIB TOSYLATE EQ 0.35MG BASE CAPSULE / ORAL RLD 2024-03-07 N217439-004 TALZENNA TALAZOPARIB TOSYLATE EQ 0.5MG BASE CAPSULE / ORAL RLD 2024-03-07 N217439-005 TALZENNA TALAZOPARIB TOSYLATE EQ 0.75MG BASE CAPSULE / ORAL RLD 2024-03-07 N217439-006 TALZENNA TALAZOPARIB TOSYLATE EQ 1MG BASE CAPSULE / ORAL RLD, RS 2024-03-07
Orange Book patents# Current patent rows page 1 of 1 · 36 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217439-001 10780088 2029-07-27 U-3651 2024-04-05 N217439-001 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-001 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-001 9820985 2029-07-27 U-2437 2024-04-05 N217439-001 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-001 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-002 10780088 2029-07-27 U-3651 2024-04-05 N217439-002 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-002 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-002 9820985 2029-07-27 U-2437 2024-04-05 N217439-002 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-002 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-003 10780088 2029-07-27 U-3651 2024-04-05 N217439-003 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-003 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-003 9820985 2029-07-27 U-2437 2024-04-05 N217439-003 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-003 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-004 10780088 2029-07-27 U-3651 2024-04-05 N217439-004 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-004 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-004 9820985 2029-07-27 U-2437 2024-04-05 N217439-004 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-004 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-005 10780088 2029-07-27 U-3651 2024-04-05 N217439-005 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-005 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-005 9820985 2029-07-27 U-2437 2024-04-05 N217439-005 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-005 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-006 10780088 2029-07-27 U-3651 2024-04-05 N217439-006 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-006 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 N217439-006 9820985 2029-07-27 U-2437 2024-04-05 N217439-006 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 N217439-006 8735392 2031-10-20 Drug substance, Drug product 2024-04-05
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217439-001 I-920 2026-06-20 N217439-002 I-920 2026-06-20 N217439-004 I-920 2026-06-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217439-001 TALZENNA EQ 0.1MG BASE CAPSULE / ORAL RLD 2024-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-002 TALZENNA EQ 0.25MG BASE CAPSULE / ORAL RLD 2024-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-003 TALZENNA EQ 0.35MG BASE CAPSULE / ORAL RLD 2024-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-004 TALZENNA EQ 0.5MG BASE CAPSULE / ORAL RLD 2024-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-005 TALZENNA EQ 0.75MG BASE CAPSULE / ORAL RLD 2024-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-006 TALZENNA EQ 1MG BASE CAPSULE / ORAL RLD, RS 2024-03-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217439-001 TALZENNA EQ 0.1MG BASE CAPSULE / ORAL RLD 2024-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217439-002 TALZENNA EQ 0.25MG BASE CAPSULE / ORAL RLD 2024-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217439-003 TALZENNA EQ 0.35MG BASE CAPSULE / ORAL RLD 2024-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217439-004 TALZENNA EQ 0.5MG BASE CAPSULE / ORAL RLD 2024-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217439-005 TALZENNA EQ 0.75MG BASE CAPSULE / ORAL RLD 2024-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217439-006 TALZENNA EQ 1MG BASE CAPSULE / ORAL RLD, RS 2024-03-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217439-001 TALZENNA EQ 0.1MG BASE CAPSULE / ORAL RLD 2024-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217439-002 TALZENNA EQ 0.25MG BASE CAPSULE / ORAL RLD 2024-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217439-003 TALZENNA EQ 0.35MG BASE CAPSULE / ORAL RLD 2024-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217439-004 TALZENNA EQ 0.5MG BASE CAPSULE / ORAL RLD 2024-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217439-005 TALZENNA EQ 0.75MG BASE CAPSULE / ORAL RLD 2024-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217439-006 TALZENNA EQ 1MG BASE CAPSULE / ORAL RLD, RS 2024-03-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217439-001 TALZENNA EQ 0.1MG BASE CAPSULE / ORAL RLD 2024-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217439-002 TALZENNA EQ 0.25MG BASE CAPSULE / ORAL RLD 2024-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217439-003 TALZENNA EQ 0.35MG BASE CAPSULE / ORAL RLD 2024-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217439-004 TALZENNA EQ 0.5MG BASE CAPSULE / ORAL RLD 2024-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217439-005 TALZENNA EQ 0.75MG BASE CAPSULE / ORAL RLD 2024-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217439-006 TALZENNA EQ 1MG BASE CAPSULE / ORAL RLD, RS 2024-03-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217439-001 TALZENNA EQ 0.1MG BASE CAPSULE / ORAL RLD 2024-03-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217439-002 TALZENNA EQ 0.25MG BASE CAPSULE / ORAL RLD 2024-03-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217439-003 TALZENNA EQ 0.35MG BASE CAPSULE / ORAL RLD 2024-03-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217439-004 TALZENNA EQ 0.5MG BASE CAPSULE / ORAL RLD 2024-03-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217439-005 TALZENNA EQ 0.75MG BASE CAPSULE / ORAL RLD 2024-03-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217439-006 TALZENNA EQ 1MG BASE CAPSULE / ORAL RLD, RS 2024-03-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217439-001 TALZENNA EQ 0.1MG BASE CAPSULE / ORAL RLD 2024-03-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217439-002 TALZENNA EQ 0.25MG BASE CAPSULE / ORAL RLD 2024-03-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217439-003 TALZENNA EQ 0.35MG BASE CAPSULE / ORAL RLD 2024-03-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217439-004 TALZENNA EQ 0.5MG BASE CAPSULE / ORAL RLD 2024-03-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217439-005 TALZENNA EQ 0.75MG BASE CAPSULE / ORAL RLD 2024-03-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217439-006 TALZENNA EQ 1MG BASE CAPSULE / ORAL RLD, RS 2024-03-07 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217439-001 TALZENNA EQ 0.1MG BASE CAPSULE / ORAL RLD 2024-03-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217439-002 TALZENNA EQ 0.25MG BASE CAPSULE / ORAL RLD 2024-03-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217439-003 TALZENNA EQ 0.35MG BASE CAPSULE / ORAL RLD 2024-03-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217439-004 TALZENNA EQ 0.5MG BASE CAPSULE / ORAL RLD 2024-03-07 2680178bc6a6…
Observed Orange Book patent history# Patent history page 1 of 14 · 540 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217439-001 10780088 2029-07-27 U-3651 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-001 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-001 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-001 9820985 2029-07-27 U-2437 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-001 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-001 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-002 10780088 2029-07-27 U-3651 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-002 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-002 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-002 9820985 2029-07-27 U-2437 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-002 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-002 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-003 10780088 2029-07-27 U-3651 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-003 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-003 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-003 9820985 2029-07-27 U-2437 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-003 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-003 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-004 10780088 2029-07-27 U-3651 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-004 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-004 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-004 9820985 2029-07-27 U-2437 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-004 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-004 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-005 10780088 2029-07-27 U-3651 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-005 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-005 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-005 9820985 2029-07-27 U-2437 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-005 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-005 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-006 10780088 2029-07-27 U-3651 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-006 8012976 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-006 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-006 9820985 2029-07-27 U-2437 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-006 10189837 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217439-006 8735392 2031-10-20 Drug substance, Drug product 2024-04-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217439-001 10780088 2029-07-27 U-3651 2024-04-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217439-001 8420650 2029-07-27 Drug substance, Drug product 2024-04-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217439-001 9820985 2029-07-27 U-2437 2024-04-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217439-001 8012976 2029-10-19 Drug substance, Drug product 2024-04-05 31067a03dcf5…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 45 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Documents# Document, Submission type, Date table Document Submission type Date 82571 SUPPL 2025-06-13 82562 SUPPL 2025-06-13 79802 ORIG 2024-10-03 77769 ORIG 2024-03-08 77762 ORIG 2024-03-08